04/03/2024
8:55 PM | Acurx Pharmaceuticals (Issuer)
DELUCCIA ROBERT J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
8:56 PM | Acurx Pharmaceuticals (Issuer)
Shawah Robert G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
8:56 PM | Acurx Pharmaceuticals (Issuer)
LUCI DAVID P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
6:31 AM | Acurx Pharmaceuticals (Subject)
| Form FWP | |
03/29/2024
3:58 PM | Acurx Pharmaceuticals (Filer)
| Form S-1/A | |
03/15/2024
3:33 PM | Acurx Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/14/2024
1:39 PM | Acurx Pharmaceuticals (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
| Form SC 13G/A | |
01/22/2024
5:15 AM | Acurx Pharmaceuticals (Issuer)
Sailer Carl (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:24 PM | Acurx Pharmaceuticals (Issuer)
LUCI DAVID P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2023
3:49 PM | Acurx Pharmaceuticals (Filer)
| Form 424B5 | |
11/14/2023
3:05 PM | Acurx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2023
3:41 PM | Acurx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
6:10 AM | Acurx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
3:05 PM | Acurx Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/13/2023
3:32 PM | Acurx Pharmaceuticals (Filer)
| Form 424B3 | |
07/10/2023
11:15 PM | Acurx Pharmaceuticals (Filer)
| Form EFFECT | |
06/20/2023
3:44 PM | Acurx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
4:45 PM | Acurx Pharmaceuticals (Issuer)
Scodari Joseph C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:45 PM | Acurx Pharmaceuticals (Issuer)
Sailer Carl (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:45 PM | Acurx Pharmaceuticals (Issuer)
DEAN JACK H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:46 PM | Acurx Pharmaceuticals (Issuer)
HARRISON THOMAS L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:46 PM | Acurx Pharmaceuticals (Issuer)
Donohue James J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2023
6:00 AM | Acurx Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
